Trial intelligence / Profile preview

MN-221 in moderate to severe asthma

NCT00679263Phase 2Completed

Sponsor
MediciNova, Inc.
Start
Feb 2008
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of bedoradrine in asthma, sponsored by MediciNova, Inc.. Started Feb 2008; status: completed.

02

Drugs

bedoradrine
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00679263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00679263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call